ADAP β€” ADAPTIMMUNE THERAPEUTICS-ADR

Ownership history in CITADEL ADVISORS LLC  Β·  71 quarters on record

This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in ADAPTIMMUNE THERAPEUTICS-ADR (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.01% (2020 Q2)
πŸ“Š Avg. % of fund
0.0%
πŸ“… First filed
2015 Q2
πŸ“… Last filed
2025 Q3
⏱ Quarters held
71
% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 143,500 +5,800 +4.2% 0.00% $19K β€”
2025 Q3 ADDED 137,700 +123,500 +869.7% 0.00% $18K β€”
2025 Q1 REDUCED 14,200 -47,700 -77.1% 0.00% $3K β€”
2025 Q1 REDUCED 61,900 -113,152 -64.6% 0.00% $12K β€”
2024 Q4 ADDED 175,052 +158,752 +973.9% 0.00% $94K β€”
2024 Q4 ADDED 16,300 +1,600 +10.9% 0.00% $9K β€”
2024 Q4 ADDED 14,700 +8,900 +153.4% 0.00% $8K β€”
2024 Q3 REDUCED 5,800 -22,300 -79.4% 0.00% $6K β€”
2024 Q3 REDUCED 28,100 -114,791 -80.3% 0.00% $27K β€”
2024 Q2 ADDED 142,891 +129,491 +966.4% 0.00% $139K β€”
61 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding ADAP

As of 2025 Q4 β€” sorted by position size

JOSH ARNOLD INVESTMENT CONSULTANT, LLC 3Y 0.03% Empirical Finance, LLC 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0% Rathbones Group PLC 3Y 7Y 0.0% SIMPLEX TRADING, LLC 3Y 7Y 0.0% RHUMBLINE ADVISERS 3Y 7Y 0.0% BARCLAYS PLC 3Y 7Y 0.0%
← Back to CITADEL ADVISORS LLC Holdings